Morepen Laboratories Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

16 Nov 2018 | 03:59 PM

22.30
-0.75 (-3.25%)

  • Outperforms Index

    16.15%

    Return (1Y)

    Beaten S&P BSE Healthcare by 10.66%

  • More Volatile

    4.2%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 3.09%

  • Not so consistent

    5/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

44

44.35

19

18.95

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Morepen Laboratories Ltd has increased by 25.21% since past 3 Months

  • FII shareholding in Morepen Laboratories Ltd has increased by 11388.3% since past 1 Year

Loading...